Audio is streamed directly from the publisher (track.fstry.me) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
上週美國藥廠輝瑞（Pfizer）和德國生技公司BioNTech宣佈，雙方合作研發的COVID-19候選疫苗「BNT162b2」效力達90%以上，讓全球市場歡聲雷動！兩家公司昨（18）日表示，根據最終分析結果，該疫苗的有效性達95%，並有望在今年耶誕節前就能開始配發，帶動輝瑞和BioNTech股價雙雙走揚，近日更積極申請FDA授權，先前FDA也表示，將謹慎、快速地給予該疫苗授權。
｜更多新聞｜
◎台視新聞訂閱→
https://www.youtube.com/c/ttvnewsview
◎台視直播訂閱→
https://www.youtube.com/c/twlivenews
◎台視臉書粉絲團訂閱→
https://www.facebook.com/ttvnews/
◎台視新聞IG訂閱→
https://www.instagram.com/ttvnews_tw/